Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients
Sign Up to like & getrecommendations! Published in 2020 at "Osteoporosis International"
DOI: 10.1007/s00198-020-05498-7
Abstract: Summary Oral bisphosphonates are effective medications for the prevention of fractures in people suffering from osteoporosis. They are associated with gastrointestinal adverse reactions the most severe being an esophageal ulcer. It is unclear if oral… read more here.
Keywords: upper gastrointestinal; oral bisphosphonate; gastrointestinal safety; bisphosphonate hospitalized ... See more keywords
Effectiveness of monthly intravenous ibandronate on the low responders to oral bisphosphonate: the MOVEMENT study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Bone and Mineral Metabolism"
DOI: 10.1007/s00774-019-01005-z
Abstract: The MOVEMENT study was designed to assess the effectiveness of monthly intravenous ibandronate on bone mineral density (BMD) in daily clinical practice in Japanese patients with primary osteoporosis whose lumbar spine BMD did not increase… read more here.
Keywords: oral bisphosphonate; intravenous ibandronate; study; spine bmd ... See more keywords
Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta‐Analysis of Six Randomized Placebo‐Controlled Trials
Sign Up to like & getrecommendations! Published in 2020 at "Orthopaedic Surgery"
DOI: 10.1111/os.12611
Abstract: To assess the effectiveness and safety of oral bisphosphonates in increasing bone mineral density (BMD), reducing fractures, and improving clinical function in patients with osteogenesis imperfecta (OI). read more here.
Keywords: oral bisphosphonate; systematic review; therapy osteogenesis; imperfecta systematic ... See more keywords